Table 2.
Comparison of patients’ outcomes between endoscopic ablation and radical nephroureterectomy.
| Outcome | Weighted Cohort [%/Median (IQR)] | p | |
|---|---|---|---|
| EA | RNU | ||
| 5-year OS | 94.5 | 94.6 | 0.987 |
| 5-year PFS | 58.6 | 55.8 | 0.883 |
| 5-year bladder cancer RFS | 75.2 | 55.8 | 0.250 |
| Creatinine increasing after operation | 77.2 | 94.4 | 0.131 |
| eGFR changes after operation | 0.0 (−11.0, 0.0) | −20.2 (−40.9, −13.0) | <0.001 |
| CKD status worse | 13.2 | 46.5 | 0.026 |
eGFR, estimated glomerular filtration rate; CKD, chronic kidney disease; IQR, interquartile range; EA, endoscopic ablation; RNU, radical nephroureterectomy; OS, overall survival; PFS, progression-free survival; RFS, recurrence-free survival.